Targeted Oncology™ Community Case Forum™
Tuesday June 10, 2025 | 5:45 - 8:30 PM CT
Hyatt Regency St. Louis at The Arch | St. Louis, MO
CONNECT WITH THE COMMUNITY
The Community Case Forum is a special opportunity to gather IN-PERSON only.
No virtual options are available.
After arriving at registration check-in, you'll spend some time networking with peers while enjoying small plate refreshments and cocktails. Case-based discussions will follow the networking reception and the evening will adjourn by 8:30 PM.
Eligibility
Participants must be medical oncologists or hematologists currently treating patients in a community practice setting. With prior approval from our registration team, a small number of fellows and advanced practice providers may be eligible to attend.
Discussion Topics
You choose the topic that is best aligned for the patients you're seeing in your practice now. Our moderators will present case-based clinical profiles to generate discussion among participants around recent clinical data and potential treatment strategies.
Discussion Topics Include:
Updates in the Treatment of Chronic Lymphocytic Leukemia
During this conversation, we will explore two cases, one case relapsed CLL and one of treatment naïve CLL.
Moderated by: John Allan, MD (Weill Cornell Medical College)
Practice Updates in Immunotherapy for Metastatic NSCLC
During this conversation, we will explore two clinical cases of advanced non-driver-mutated NSCLC, one of metastatic NSCLC with high PD-L1 expression and one of stage III NSCLC.
Moderated by: Bruna Pellini, MD (Moffitt Cancer Center)
MARKET RESEARCH PARTICIPATION
Seating is limited, and registration will close when capacity is reached.
Reserve your seat today for the Targeted Oncology Community Case Forum.
Presented in Partnership With:
Targeted Healthcare Communications® — an MJH Life Sciences® Brand
Copyright 2025 © Intellisphere, LLC. All Rights Reserved.